Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321845329> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4321845329 endingPage "58" @default.
- W4321845329 startingPage "52" @default.
- W4321845329 abstract "According to WHO data, cardiovascular diseases occupy a leading position in terms of the number per share of the population, both in Russia and in other countries. A prerequisite for the development of these pathologies is atherosclerosis. It is now recognized that drug therapy is leading in curbing the development of atherosclerosis and subsequent complications. In this regard, the urgency of the search for new lipid-lowering drugs aimed at the treatment of this disease is increasing. Recent studies have shown the promise of using the benzothiophene backbone for the synthesis of new effective drugs, since this core has various biological and pharmacological activities, which makes it possible to obtain effective antimicrobial, anticancer, anti-inflammatory, antioxidant, anti-tuberculosis, antidiabetic, anticonvulsant and other drugs on its basis.The purpose of this study was to study the lipid-lowering effect of the azomethine derivative 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, a substance under the laboratory code BF-10, on some indicators of lipid metabolism in healthy rats and under pathological conditions with experimental hyperlipidemia. Atorvastatin was chosen as the reference drug. Determination of biochemical parameters of lipid metabolism in the blood serum and in the liver homogenate (the content of cholesterol, triglycerides, total lipids, LDL, VLDL and HDL) was determined by unified biochemical methods using standard Olvex Diagnosticum kits on a Dixion Torus 120 analyzer. Based on the analysis of the obtained data on the effect of the BF-10 substance on lipid metabolism, it can be concluded that they are comparable with the action of the highly effective reference drug atorvastatin, which allows us to expand information on the spectrum of biological activity of azomethine derivatives and consider the compound under the laboratory code BF-10 promising for further development." @default.
- W4321845329 created "2023-02-25" @default.
- W4321845329 creator A5001901668 @default.
- W4321845329 creator A5011694432 @default.
- W4321845329 creator A5019930830 @default.
- W4321845329 creator A5031756758 @default.
- W4321845329 creator A5064126426 @default.
- W4321845329 creator A5073837097 @default.
- W4321845329 date "2022-12-30" @default.
- W4321845329 modified "2023-09-27" @default.
- W4321845329 title "INFLUENCE OF PURPOSEFULLY SYNTHESIZED AZOMETHINE DERIVATIVE OF TETRAHYDROBENZOTHIOPHENE-3-CARBOXAMIDE ON SOME INDICATORS OF LIPID METABOLISM IN HEALTHY RATS AND UNDER CONDITIONS OF EXPERIMENTAL HYPERLIPIDEMIA" @default.
- W4321845329 cites W3171983805 @default.
- W4321845329 cites W3199481048 @default.
- W4321845329 cites W4214844750 @default.
- W4321845329 doi "https://doi.org/10.26787/nydha-2618-8783-2022-7-4-52-58" @default.
- W4321845329 hasPublicationYear "2022" @default.
- W4321845329 type Work @default.
- W4321845329 citedByCount "0" @default.
- W4321845329 crossrefType "journal-article" @default.
- W4321845329 hasAuthorship W4321845329A5001901668 @default.
- W4321845329 hasAuthorship W4321845329A5011694432 @default.
- W4321845329 hasAuthorship W4321845329A5019930830 @default.
- W4321845329 hasAuthorship W4321845329A5031756758 @default.
- W4321845329 hasAuthorship W4321845329A5064126426 @default.
- W4321845329 hasAuthorship W4321845329A5073837097 @default.
- W4321845329 hasConcept C134018914 @default.
- W4321845329 hasConcept C139572402 @default.
- W4321845329 hasConcept C185592680 @default.
- W4321845329 hasConcept C2777482532 @default.
- W4321845329 hasConcept C2778163477 @default.
- W4321845329 hasConcept C2779091943 @default.
- W4321845329 hasConcept C2779496979 @default.
- W4321845329 hasConcept C2780035454 @default.
- W4321845329 hasConcept C2908647359 @default.
- W4321845329 hasConcept C2909799055 @default.
- W4321845329 hasConcept C4733338 @default.
- W4321845329 hasConcept C55493867 @default.
- W4321845329 hasConcept C555293320 @default.
- W4321845329 hasConcept C71924100 @default.
- W4321845329 hasConcept C98274493 @default.
- W4321845329 hasConcept C99454951 @default.
- W4321845329 hasConceptScore W4321845329C134018914 @default.
- W4321845329 hasConceptScore W4321845329C139572402 @default.
- W4321845329 hasConceptScore W4321845329C185592680 @default.
- W4321845329 hasConceptScore W4321845329C2777482532 @default.
- W4321845329 hasConceptScore W4321845329C2778163477 @default.
- W4321845329 hasConceptScore W4321845329C2779091943 @default.
- W4321845329 hasConceptScore W4321845329C2779496979 @default.
- W4321845329 hasConceptScore W4321845329C2780035454 @default.
- W4321845329 hasConceptScore W4321845329C2908647359 @default.
- W4321845329 hasConceptScore W4321845329C2909799055 @default.
- W4321845329 hasConceptScore W4321845329C4733338 @default.
- W4321845329 hasConceptScore W4321845329C55493867 @default.
- W4321845329 hasConceptScore W4321845329C555293320 @default.
- W4321845329 hasConceptScore W4321845329C71924100 @default.
- W4321845329 hasConceptScore W4321845329C98274493 @default.
- W4321845329 hasConceptScore W4321845329C99454951 @default.
- W4321845329 hasLocation W43218453291 @default.
- W4321845329 hasOpenAccess W4321845329 @default.
- W4321845329 hasPrimaryLocation W43218453291 @default.
- W4321845329 hasRelatedWork W2034257469 @default.
- W4321845329 hasRelatedWork W2287384162 @default.
- W4321845329 hasRelatedWork W2404328631 @default.
- W4321845329 hasRelatedWork W2410845698 @default.
- W4321845329 hasRelatedWork W2419328296 @default.
- W4321845329 hasRelatedWork W2492344783 @default.
- W4321845329 hasRelatedWork W2614884414 @default.
- W4321845329 hasRelatedWork W2702592209 @default.
- W4321845329 hasRelatedWork W2914838373 @default.
- W4321845329 hasRelatedWork W4321845329 @default.
- W4321845329 isParatext "false" @default.
- W4321845329 isRetracted "false" @default.
- W4321845329 workType "article" @default.